预期保险覆盖与医药创新：来自中国国家药品价格谈判政策的证据

标题	预期保险覆盖与医药创新：来自中国国家药品价格谈判政策的证据
日期和时间	2025年11月27日（周四） 13:30-15:00
地点	综合教学楼D904会议室
主讲人	刘晨源教授清华大学
摘要	How can developing countries promote pharmaceutical innovation when drug price negotiations risk eroding firms’ incentives? China’s National Health Insurance Drug Price Negotiation addresses this challenge by pairing substantial price cuts with expanded insurance coverage for innovative drugs, enlarging the effective market size. We examine its impact on innovation using a difference-in-differences design that compares clinical trials for new drugs (treated) to those for vaccines (unaffected). The policy increases the number of trials by 0.77 per disease per year. The effects are driven by both new firms entering the market and incumbent firms conducting more clinical trials. We also find the effects exist for both domestic and foreign firms, and the policy induced more firm collaboration.
主讲人简介	刘晨源现任清华大学经济管理学院经济系助理教授。她在美国威斯康星大学麦迪逊分校获得风险与保险方向的商业博士学位，并于香港大学取得经济学学士学位。她的研究领域包括健康经济学、保险经济学以及实证产业组织。其学术成果已发表于American Economic Journal: Economic Policy、Journal of Health Economics等国际学术期刊。